Biological E. Limited Enoxaparin Export Data — India (DGFT 2022–2026)

Name: Biological E. Limited Enoxaparin Export Records India — #3 Exporter, 226 Shipments, $11.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Enoxaparin

India Pharmaceutical Trade Intelligence

$209.4M223 Suppliers118 CountriesHS 30049099

ExportsIndia → UNITED STATES49.0%India → SAUDI ARABIA22.0%

ImportsFRANCE → India$2.7B CHINA → India$3.2M

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Biological E. Limited — Enoxaparin Exporter #3 | $12.8M Trade Value | TransData Nexus | TransData Nexus

Biological E. Limited — Enoxaparin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Enoxaparin · $12.8M export value · DGFT Verified

Biological E. Limited is the #3 Indian exporter of Enoxaparin with $12.8M in export value and 226 verified shipments. Biological E. Limited holds a 5.4% market share in Enoxaparin exports across 5 countries. The company exports 5 pharmaceutical products worth $80.3M across 3 therapeutic categories.

Biological E. Limited — Enoxaparin Export Profile: Buyers & Destinations

Biological E. Limited Enoxaparin export treemap — buyers and destination countries | TransData Nexus

Where Does Biological E. Limited Export Enoxaparin?

Country	Value	Shipments	Share
UNITED STATES	$6.8M	144	61.2%
CANADA	$3.8M	98	34.1%
THAILAND	$266.3K	7	2.4%
MEXICO	$250.0K	5	2.2%

Who Are the Top Buyers of Enoxaparin from Biological E. Limited?

Buyer	Country	Value	Orders
BE PHARMACEUTICALS INC	UNITED STATES	$6.5M	138
FRESENIUS KABI CANADA LTD	CANADA	$3.4M	87
FRESENIUS KABI CANADA LTD.	CANADA	$316.6K	7
BE PHARMACEUTICALS INC.	UNITED STATES	$275.5K	6
STADA(THAILAND) COMPANY LIMIT 8T	THAILAND	$224.7K	6
CARITAS PHARMA S.A DE C.V	MEXICO	$150.0K	3
CARITAS PHARMA S A DE C V	MEXICO	$100.0K	2
STADA THAILAND COMPANY LIMIT 8T	THAILAND	$41.7K	1
FRESENIUS KABI CANADA LIMITED	CANADA	$35.6K	2
MS. HELEN ZOGGAS, SAMPLE	CANADA	$219	2

Biological E. Limited supplies Enoxaparin to 11 buyers globally. The largest buyer is BE PHARMACEUTICALS INC (UNITED STATES), followed by FRESENIUS KABI CANADA LTD (CANADA) and FRESENIUS KABI CANADA LTD. (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Enoxaparin Formulations Does Biological E. Limited Export?

Product Description / Formulation	Value	Shipments
ENOXAPARIN SODIUM INJECTION USP 40MG/0.4ML	$1.8M	36
51000441 - ENOXAPARIN SODIUM INJECTION,	$1.1M	24
51000440 - ENOXAPARIN SODIUM INJECTION,	$616.1K	14
ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLNOS	$553.9K	14
51000444 - ENOXAPARIN SODIUM INJECTION,	$462.3K	14
ENOXAPARIN SODIUM INJECTION USP 30MG/0.3ML	$412.2K	9
ENOXAPARIN SODIUM INJECTION USP 60MG/0.6ML	$348.1K	8
51000446 - ENOXAPARIN SODIUM INJECTION,	$300.0K	6
ENOXAPARIN SODIUM INJECTION USP 80MG/0.8ML	$300.0K	6
ENOXAPARIN SODIUM INJECTION USP 100MG/1ML	$290.9K	6

Biological E. Limited exports 69 distinct Enoxaparin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ENOXAPARIN SODIUM INJECTION USP 40MG/0.4ML with 36 shipments worth $1.8M.

How Does Biological E. Limited Compare to Nearest Enoxaparin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	GLAND PHARMA LTD	$33.5M	669	25	$50.0K
1	GLAND PHARMA LIMITED	$24.8M	495	25	$50.0K
3	BIOLOGICAL E. LIMITED ★	$11.3M	226	5	$50.0K
4	VENUS REMEDIES LIMITED	$5.1M	182	22	$27.8K
6	EMCURE PHARMACEUTICALS LIMITED	$4.1M	187	16	$21.8K

Biological E. Limited ranks #3 among 223 Indian Enoxaparin exporters. Average shipment value of $50.0K compared to the market average of $397.9K. The closest competitors by value are GLAND PHARMA LTD and GLAND PHARMA LIMITED.

Which Indian Ports Ship Enoxaparin Exports?

Port	Shipments	% Share
HYDERABAD ICD	555	16.8%
HYDERABAD ICD (INSNF6)	455	13.8%
SAHAR AIR CARGO ACC (INBOM4)	276	8.3%
SAHAR AIR	251	7.6%
DELHI AIR CARGO ACC (INDEL4)	165	5.0%
DELHI AIR	159	4.8%
NHAVA SHEVA SEA (INNSA1)	150	4.5%
HYDERABAD AIR	120	3.6%

Geopolitical & Trade Policy Impact on Biological E. Limited's Enoxaparin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like BE. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight charges and potential losses estimated between ₹2,500 crore and ₹5,000 crore for the Indian pharma industry in March 2026. (fortuneindia.com) These disruptions can elongate lead times and elevate cold-chain failure risks, particularly for temperature-sensitive products like vaccines. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have prompted the U.S. to seek alternative suppliers, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the U.S. in August 2025 posed challenges, with Indian exporters facing increased costs and competitive disadvantages. (apnews.com) The subsequent withdrawal of tariffs on generic drugs in October 2025 provided some relief, yet the episode underscores the volatility of trade policies and the need for exporters to remain agile. (medboundtimes.com)

In the European Union, compliance with the Falsified Medicines Directive requires stringent serialization and traceability measures. For companies like BE, ensuring adherence to these regulations is crucial to maintain market access and uphold their reputation for quality.

Biological E. Limited — Regulatory Compliance & Quality Standards

Regulatory compliance remains a cornerstone for Indian pharmaceutical exporters. The U.S. FDA has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. (fact.net.in) Instances of quality issues and FDA warnings have previously affected the reputation of Indian pharma exports. (svhealthcare.in) For BE, maintaining compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP) is imperative to sustain and expand its export footprint.

The company's recent WHO pre-qualification for nOPV2 reflects its commitment to quality and regulatory excellence. However, the broader industry faces challenges related to counterfeit drugs and quality concerns, which can impact India's reputation as a reliable supplier. (fact.net.in) Proactive measures, including robust quality assurance systems and transparent governance, are essential for BE to navigate this evolving landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Enoxaparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biological E. Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 255 individual customs records matching Biological E. Limited exporting Enoxaparin, covering 69 formulations to 5 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 118+ countries, 505+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Enoxaparin

Enoxaparin

Biological E. Limited — Enoxaparin Exporter Profile

Biological E. Limited — Enoxaparin Export Profile: Buyers & Destinations

Where Does Biological E. Limited Export Enoxaparin?

Who Are the Top Buyers of Enoxaparin from Biological E. Limited?

What Is India's Total Enoxaparin Export Value and How Much Does Biological E. Limited Contribute?

What Is the Average Shipment Value for Biological E. Limited's Enoxaparin Exports?

How Does Biological E. Limited Compare to Other Indian Enoxaparin Exporters?

What Enoxaparin Formulations Does Biological E. Limited Export?

Regulatory Requirements: Exporting Enoxaparin to Key Markets

United States — FDA

Canada — HC

How Does Biological E. Limited Compare to Nearest Enoxaparin Exporters?

Which Indian Ports Ship Enoxaparin Exports?

What Other Cardiovascular Products Does Biological E. Limited Export?

Geopolitical & Trade Policy Impact on Biological E. Limited's Enoxaparin Exports

Biological E. Limited — Regulatory Compliance & Quality Standards

About Biological E. Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Enoxaparin Export Data from Biological E. Limited

Enoxaparin Stats

Company Overview

Top Products by Biological E. Limited

Related Analysis

Need Detailed Export Data?

Data Source